MetLife, Inc. (NYSE:MET – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $93.4167.
Several equities research analysts have weighed in on MET shares. Morgan Stanley cut their target price on shares of MetLife from $101.00 to $93.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. UBS Group boosted their price target on shares of MetLife from $94.00 to $98.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Weiss Ratings downgraded MetLife from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, March 9th. Wells Fargo & Company reduced their target price on MetLife from $97.00 to $93.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Finally, Evercore set a $95.00 target price on MetLife in a research note on Tuesday, February 10th.
View Our Latest Stock Analysis on MET
Institutional Trading of MetLife
MetLife Stock Performance
Shares of MET stock opened at $70.74 on Friday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20. The stock has a market cap of $46.12 billion, a PE ratio of 15.05, a price-to-earnings-growth ratio of 0.63 and a beta of 0.74. The stock has a 50-day moving average of $73.63 and a 200-day moving average of $77.20. MetLife has a one year low of $65.21 and a one year high of $83.85.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share for the quarter, topping the consensus estimate of $2.34 by $0.15. The business had revenue of $52.44 billion for the quarter, compared to analyst estimates of $31.43 billion. MetLife had a net margin of 4.38% and a return on equity of 21.81%. MetLife’s quarterly revenue was up 27.6% compared to the same quarter last year. During the same quarter last year, the firm earned $2.08 EPS. As a group, sell-side analysts expect that MetLife will post 9.65 earnings per share for the current year.
MetLife Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 3rd were issued a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a dividend yield of 3.2%. The ex-dividend date was Tuesday, February 3rd. MetLife’s payout ratio is 48.30%.
MetLife Company Profile
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
See Also
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
